Quest Diagnostics Inc Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings
Quest Diagnostics Inc (DGX) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings of -$3.00 million for the 12-month period ending 2014-12-31, per its 10-K filed 2015-02-24.
Discontinued › Income Statement › Other Income
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1 · last filed 2015-02-24
- Quest Diagnostics Inc fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, gain (loss) included in earnings for the quarter ending 2013-12-31 was -$1.05M.
- Quest Diagnostics Inc fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, gain (loss) included in earnings for the quarter ending 2013-09-30 was -$2.10M.
- Quest Diagnostics Inc fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, gain (loss) included in earnings for the quarter ending 2013-06-30 was -$740.00K.
- Quest Diagnostics Inc fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, gain (loss) included in earnings for the quarter ending 2013-03-31 was -$110.00K.
- Quest Diagnostics Inc fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, gain (loss) included in earnings for fiscal 2014 was -$3.00M.
- Quest Diagnostics Inc fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, gain (loss) included in earnings for fiscal 2013 was -$4.00M.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings 3 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings 6 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings 9 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings 12 month |
|---|---|---|---|---|
| 2014-12-31 | -$3.00M 10-K · filed 2015-02-24 | |||
| 2013-12-31 | -$1.05M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | -$3.15M derived: sum of 2 quarters · filed 2015-02-24 | -$3.89M derived: sum of 3 quarters · filed 2015-02-24 | -$4.00M 10-K · filed 2015-02-24 |
| 2013-09-30 | -$2.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-24 | -$2.84M derived: sum of 2 quarters · filed 2013-10-24 | -$2.95M 10-Q · filed 2013-10-24 | |
| 2013-06-30 | -$740.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-25 | -$850.00K 10-Q · filed 2013-07-25 | ||
| 2013-03-31 | -$110.00K 10-Q · filed 2013-04-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |